AAAAAA

   
Results: 1-7 |
Results: 7
Biodistribution, blood half-life, and receptor binding of a somatostatin-dextran conjugate
Authors: Behe, M Du, J Becker, W Behr, T Angerstein, C Marquez, M Hiltunen, J Nilsson, S Holmberg, AR
Citation: M. Behe et al., Biodistribution, blood half-life, and receptor binding of a somatostatin-dextran conjugate, MED ONCOL, 18(1), 2001, pp. 59-64
Tc-99m-E-selectin binding peptide for imaging acute osteomyelitis in a novel rat model
Authors: Gratz, S Behe, M Boerman, OC Kunze, E Schulz, H Eiffert, H O'Reilly, T Behr, TM Angerstein, C Nebendahl, K Kauer, F Becker, W
Citation: S. Gratz et al., Tc-99m-E-selectin binding peptide for imaging acute osteomyelitis in a novel rat model, NUCL MED C, 22(9), 2001, pp. 1003-1013
Therapeutic advantages of Auger electron- over beta-emitting radiometals or radioiodine when conjugated to internalizing antibodies
Authors: Behr, TM Behe, M Lohr, M Sgouros, G Angerstein, C Wehrmann, E Nebendahl, K Becker, W
Citation: Tm. Behr et al., Therapeutic advantages of Auger electron- over beta-emitting radiometals or radioiodine when conjugated to internalizing antibodies, EUR J NUCL, 27(7), 2000, pp. 753-765
Studies on the red marrow dosimetry in radioimmunotherapy: An experimentalinvestigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters
Authors: Behr, TM Sgouros, G Stabin, MG Behe, M Angerstein, C Blumenthal, RD Apostolidis, C Molinet, R Sharkey, RM Koch, L Goldenberg, DM Becker, W
Citation: Tm. Behr et al., Studies on the red marrow dosimetry in radioimmunotherapy: An experimentalinvestigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters, CLIN CANC R, 5(10), 1999, pp. 3031S-3043S
Cholecystokinin-B/gastrin receptor binding peptides: Preclinical development and evaluation of their diagnostic and therapeutic potential
Authors: Behr, TM Behe, M Angerstein, C Gratz, S Mach, R Hagemann, L Jenner, N Stiehler, M Frank-Raue, K Raue, F Becker, W
Citation: Tm. Behr et al., Cholecystokinin-B/gastrin receptor binding peptides: Preclinical development and evaluation of their diagnostic and therapeutic potential, CLIN CANC R, 5(10), 1999, pp. 3124S-3138S
Radioimmunotherapy of small volume disease of colorectal cancer metastaticto the liver: Preclinical evaluation in comparison to standard chemotherapy and initial results of a phase I clinical study
Authors: Behr, TM Salib, AL Liersch, T Behe, M Angerstein, C Blumenthal, RD Fayyazi, A Sharkey, RM Ringe, B Becker, H Wormann, B Hiddemann, W Goldenberg, DM Becker, W
Citation: Tm. Behr et al., Radioimmunotherapy of small volume disease of colorectal cancer metastaticto the liver: Preclinical evaluation in comparison to standard chemotherapy and initial results of a phase I clinical study, CLIN CANC R, 5(10), 1999, pp. 3232S-3242S
Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors
Authors: Behr, TM Jenner, N Behe, M Angerstein, C Gratz, S Raue, F Becker, W
Citation: Tm. Behr et al., Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors, J NUCL MED, 40(6), 1999, pp. 1029-1044
Risultati: 1-7 |